C. Boyd Clarke, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 3,000 shares at $3.69 ($11K) on 2014-08-06, disclosed to the SEC on 2014-08-07.
Open-market purchase of $11k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.